A phase II study of bendamustine plus rituximab in Japanese patients with relapsed or refractory indolent B-cell non-Hodgkin lymphoma and mantle cell lymphoma previously treated with rituximab: BRB study. [electronic resource]
Producer: 20160212Description: 554-62 p. digitalISSN:- 1865-3774
- Adult
- Aged
- Antineoplastic Agents -- administration & dosage
- Antineoplastic Combined Chemotherapy Protocols -- administration & dosage
- B-Lymphocytes -- drug effects
- Bendamustine Hydrochloride -- adverse effects
- Drug Administration Schedule
- Female
- Humans
- Leukopenia -- chemically induced
- Lymphoma, B-Cell -- drug therapy
- Lymphoma, Mantle-Cell -- drug therapy
- Male
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Neutropenia -- chemically induced
- Rituximab -- administration & dosage
- Treatment Outcome
- Young Adult
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article
There are no comments on this title.
Log in to your account to post a comment.